Literature DB >> 33323943

Real-time intraoperative diagnosis by deep neural network driven multiphoton virtual histology.

Sixian You1,2, Yi Sun1,3, Lin Yang4, Jaena Park1,2, Haohua Tu1, Marina Marjanovic1,2,5, Saurabh Sinha6,7, Stephen A Boppart8,9,10,11.   

Abstract

Recent advances in label-free virtual histology promise a new era for real-time molecular diagnosis in the operating room and during biopsy procedures. To take full advantage of the rich, multidimensional information provided by these technologies, reproducible and reliable computational tools that could facilitate the diagnosis are in great demand. In this study, we developed a deep-learning-based framework to recognize cancer versus normal human breast tissue from real-time label-free virtual histology images, with a tile-level AUC (area under receiver operating curve) of 95% and slide-level AUC of 100% on unseen samples. Furthermore, models trained on a high-quality laboratory-generated dataset can generalize to independent datasets acquired from a portable intraoperative version of the imaging technology with a physics-based adapted design. Classification activation maps and final feature visualization revealed discriminative patterns, such as tumor cells and tumor-associated vesicles, that are highly associated with cancer status. These results demonstrate that through the combination of real-time virtual histopathology and a deep-learning framework, accurate real-time diagnosis could be achieved in point-of-procedure clinical applications.

Year:  2019        PMID: 33323943     DOI: 10.1038/s41698-019-0104-3

Source DB:  PubMed          Journal:  NPJ Precis Oncol        ISSN: 2397-768X


  2 in total

1.  Histology safety: now and then.

Authors:  René J Buesa
Journal:  Ann Diagn Pathol       Date:  2007-10       Impact factor: 2.090

2.  Large field, high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessment.

Authors:  Osnath Assayag; Martine Antoine; Brigitte Sigal-Zafrani; Michael Riben; Fabrice Harms; Adriano Burcheri; Kate Grieve; Eugénie Dalimier; Bertrand Le Conte de Poly; Claude Boccara
Journal:  Technol Cancer Res Treat       Date:  2013-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.